Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing α-methylphenylalanyl based phosphotyrosyl mimetics

被引:21
作者
Oishi, S
Karki, RG
Kang, SU
Wang, XZ
Worthy, KM
Bindu, LK
Nicklaus, MC
Fisher, RJ
Burke, TR
机构
[1] NCI, CCR, Med Chem Lab, NIH, Frederick, MD 21702 USA
[2] Sci Applicat Int Corp, Prot Chem Lab, Frederick, MD 21702 USA
关键词
D O I
10.1021/jm0492709
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previous work has shown that incorporation of either I-aminocyclohexanecarboxylic acid (Ac(6)c) or alpha-methyl-p-phosphonophenylalanine ((alpha-Me)Ppp) in the phosphotyrosyl (pTyr) C-proximal position (pY + 1 residue) of Grb2 SH2 domain binding peptides confers high affinity. The tetralin-based (S)-2-amino-6-phosphonotetralin-2-carboxylic acid (Atc(6-(POH2)-H-3)) simultaneously presents structural features of both (a-Me)Ppp and Ac(6)c residues. The current study compares the affinity of this tetralin hybrid Atc(6-PO3H2) versus Ac(6)c and (alpha-Me)Ppp residues when incorporated into the pY + I position of a high-affinity Grb2 SH2 domain binding tripeptide platform. The highest binding affinity (K-D = 14.8 nM) was exhibited by the (alpha-Me)Ppp-containing parent, with the corresponding Ac(6)c-containing peptide being nearly 2-fold less potent (K-D = 23.8 nM). The lower KD value was attributable primarily to a 50% increase in off-rate. Replacement of the Ac(6)c residue with the tetralin-based hybrid resulted in a further 4-fold decrease in binding affnity (K-D = 97.8 nM), which was the result of a further 6-fold increase in off-rate, offset by an approximate 45% increase in on-rate. Therefore, by incorporation of the key structural components found in (alpha-Me)Ppp into the Ac(6)c residue, the tetralin hybrid does enhance binding on-rate. However, net binding affinity is decreased due to an associated increase in binding off-rate. Alternatively, global conformational constraint of an ((alpha-Me)Ppp-containing peptide by beta-macrocyclization did result in pronounced elevation of binding affinity, which was achieved primarily through a decrease in the binding off-rate. Mathematical fitting using a simple model that assumed a single binding site yielded an effective KD of 2.28 nM. However this did not closely approximate the data obtained. Rather, use of a complex model that assumed two binding sites resulted in a very close fit of data and provided KD values of 97 pM and 72 nM for the separate sites, respectively. Therefore, although local conformational constraint in the pY + 1 residue proved to be deleterious, global conformational constraint through beta-macrocyclization achieved higher affinity. Similar beta-macrocyclization may potentially be extended to SH2 domain systems other than Grb2, where bend geometries are required.
引用
收藏
页码:764 / 772
页数:9
相关论文
共 30 条
[1]   TETRAMETHYLFLUOROFORMAMIDINIUM HEXAFLUOROPHOSPHATE - A RAPID-ACTING PEPTIDE COUPLING REAGENT FOR SOLUTION AND SOLID-PHASE PEPTIDE-SYNTHESIS [J].
CARPINO, LA ;
EL-FAHAM, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5401-5402
[2]  
DALY RJ, 1994, ONCOGENE, V9, P2723
[3]   Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: Implications for human breast cancer [J].
Dankort, D ;
Maslikowski, B ;
Warner, N ;
Kanno, N ;
Kim, H ;
Wang, ZX ;
Moran, MF ;
Oshima, RG ;
Cardiff, RD ;
Muller, WJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1540-1551
[4]   RECOGNITION OF A HIGH-AFFINITY PHOSPHOTYROSYL PEPTIDE BY THE SRC HOMOLOGY-2 DOMAIN OF P56(LCK) [J].
ECK, MJ ;
SHOELSON, SE ;
HARRISON, SC .
NATURE, 1993, 362 (6415) :87-91
[5]   Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways [J].
Fretz, H ;
Furet, P ;
García-Echeverría, C ;
Rahuel, J ;
Schoepfer, J .
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (18) :1777-1796
[6]   Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic [J].
Furet, P ;
García-Echeverria, C ;
Gay, B ;
Schoepfer, J ;
Zeller, M ;
Rahuel, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2358-2363
[7]   Structure-based design and synthesis of nigh affinity tripeptide ligands of the Grb2-SH2 domain [J].
Furet, P ;
Gay, B ;
Caravatti, G ;
García-Echeverría, C ;
Rahuel, J ;
Schoepfer, J ;
Fretz, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3442-3449
[8]   Olefin metathesis in the design and synthesis of a globally constrained Grb2 SH2 domain inhibitor [J].
Gao, Y ;
Wei, CQ ;
Burke, TR .
ORGANIC LETTERS, 2001, 3 (11) :1617-1620
[9]   Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor [J].
Gao, Y ;
Voigt, J ;
Wu, JX ;
Yang, DJ ;
Burke, TR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) :1889-1892
[10]   Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70 [J].
García-Echeverría, C .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (13) :1589-1604